British
and Irish Legal Information Institute
Freely Available British and Irish Public Legal Information
[
Home]
[
Databases]
[
World Law]
[
Multidatabase Search]
[
Help]
[
Feedback]
United Kingdom Intellectual Property Office Decisions
You are here:
BAILII >>
Databases >>
United Kingdom Intellectual Property Office Decisions >>
Neurim Pharmaceuticals (1991) Ltd (Patent) [2009] UKIntelP o38409 (15 December 2009)
URL: http://www.bailii.org/uk/cases/UKIntelP/2009/o38409.html
Cite as:
[2009] UKIntelP o38409
[
New search]
[
Printable PDF version]
[
Help]
Neurim Pharmaceuticals (1991) Ltd [2009] UKIntelP o38409 (15 December 2009)
For the whole decision click here: o38409
Patent decision
- BL number
- O/384/09
- Concerning rights in
- SPC/GB/07/051
- Hearing Officer
- Mrs C L Davies
- Decision date
- 15 December 2009
- Person(s) or Company(s) involved
- Neurim Pharmaceuticals (1991) Ltd
- Provisions discussed
- Regulation (EC) No. 469/2009; Article 3(d)
- Keywords
- Supplementary Protection Certificates
- Related Decisions
- None
Summary
Neurim Pharmaceuticals (1991) Ltd filed an application for an SPC for the product melatonin, identifying authorisation EU/1/07/392/001 for the medicinal product Circadin - melatonin as the first authorisation to place the product on the market.
However, the Hearing Officer found that an earlier veterinary authorisation for Regulin having the active ingredient melatonin precluded the grant of an SPC based on the later authorisation for Circadin.
Since the conditions of Article 3(d) of the Regulation have therefore not been met, the Hearing Officer rejected the application for an SPC under Article 10(2).